Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William W Busse

Showing results (31-40 of 355) with videos related to

Pageof 36
Sort By:
The Journal of Allergy and Clinical Immunology|May 8, 2016
Biomarkers in asthmatic patients: Has their time come to direct treatment?Alalia Berry, William W Busse
The Medical Clinics of North America|November 14, 2002
Refractory asthmaMaureen McGeehan, William W Busse
The Journal of Allergy and Clinical Immunology|August 7, 2022
What has been learned by cytokine targeting of asthma?William W Busse, Ravi Viswanathan
The Journal of Allergy and Clinical Immunology|January 9, 2007
Addressing issues of asthma in inner-city childrenWilliam W Busse, Herman Mitchell
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2015
Biologics in asthma--the next step toward personalized treatmentJared Darveaux, William W Busse
The Journal of Allergy and Clinical Immunology|January 10, 2004
The eosinophil--quo vadis?Rafeul Alam, William W Busse
The World Allergy Organization Journal|November 16, 2013
Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the GuidelinesJean Bousquet, William W Busse
The Journal of Allergy and Clinical Immunology. in Practice|November 9, 2020
How Sex and Age of Asthma Onset Influence Difficult Asthma HeterogeneityPraveen Akuthota, William W Busse
European Respiratory Review : an Official Journal of the European Respiratory Society|January 27, 2022
Current unmet needs and potential solutions to uncontrolled asthmaWilliam W Busse, Monica Kraft
The Journal of Allergy and Clinical Immunology|June 12, 2026
Is an inhaled biologic a better approach to treat asthma?William W Busse, Ravi Viswanathan
Pageof 36

Showing results (31-40 of 355) with videos related to

Sort By:
Pageof 36
The Journal of Allergy and Clinical Immunology|May 8, 2016
Biomarkers in asthmatic patients: Has their time come to direct treatment?Alalia Berry, William W Busse
The Medical Clinics of North America|November 14, 2002
Refractory asthmaMaureen McGeehan, William W Busse
The Journal of Allergy and Clinical Immunology|August 7, 2022
What has been learned by cytokine targeting of asthma?William W Busse, Ravi Viswanathan
The Journal of Allergy and Clinical Immunology|January 9, 2007
Addressing issues of asthma in inner-city childrenWilliam W Busse, Herman Mitchell
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2015
Biologics in asthma--the next step toward personalized treatmentJared Darveaux, William W Busse
The Journal of Allergy and Clinical Immunology|January 10, 2004
The eosinophil--quo vadis?Rafeul Alam, William W Busse
The World Allergy Organization Journal|November 16, 2013
Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the GuidelinesJean Bousquet, William W Busse
The Journal of Allergy and Clinical Immunology. in Practice|November 9, 2020
How Sex and Age of Asthma Onset Influence Difficult Asthma HeterogeneityPraveen Akuthota, William W Busse
European Respiratory Review : an Official Journal of the European Respiratory Society|January 27, 2022
Current unmet needs and potential solutions to uncontrolled asthmaWilliam W Busse, Monica Kraft
The Journal of Allergy and Clinical Immunology|June 12, 2026
Is an inhaled biologic a better approach to treat asthma?William W Busse, Ravi Viswanathan
Pageof 36